An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).

Conditions: Systemic Lupus Erythematosus, SLE Interventions: Drug: PIT565 Sponsors: Novartis Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials